Trial Search
Current Search Criteria:
EXhaled Hydrogen Peroxide As a Marker of Lung diseasE (EXHALE) Pilot Study.
N/AThis Pilot study evaluates the use of a new device called Inflammacheck and...
Status
Completed
Location
Portsmouth Hospitals NHS Trust
Start Date
2016-11-14
Trial ID
NCT03055923
Treatments Being Tested
EXhaled Hydrogen Peroxide As a Marker of Lung Disease Study - Conformité Européenne (European Conformity)
N/AThis study is designed to test whether the Inflammacheck™ device is easy to...
Status
Completed
Location
Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital
Start Date
2019-06-06
Trial ID
NCT04531449
A Cross Sectional, Diagnostic Accuracy Study to Validate the Use of a New Device(Inflammacheck™) in Diagnosing COPD
N/AA cross-sectional, diagnostic accuracy study to evaluate the use of the 'In...
Status
Completed
Location
Portsmouth Hospitals NHS Trust
Start Date
2018-12-17
Trial ID
NCT04024657
Assessment of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) as Measured Using a New Device (Inflammacheck™) in Patients With Interstitial Lung Disease, Lung Cancer and Healthy Volunteers.
N/AA cross-sectional study of EBC H2O2 levels, as measured by a novel device, ...
Status
Completed
Location
Portsmouth Hospitals NHS Trust
Start Date
2018-10-30
Trial ID
NCT04061356
Study to Explore the Relationship Between the Level of Exhaled Breath Condensate Hydrogen Peroxide (EBC H2O2) as Measured Using a New Device Against Existing Measures of Lung Disease
N/AA cross-sectional, observational study of EBC H2O2 levels, as measured by a...
Status
Completed
Location
Portsmouth Hospitals NHS Trust
Start Date
2018-02-03
Trial ID
NCT04061291